AKT1 and neoplasm: In fact, AKT activation was detected in 15–64% of tumours showing aberration in a single gene, 44–89% of tumours with aberrant expression of two genes, 67–100% of tumours with aberrant expression of three genes and 100% of tumours with aberrant expression of all four genes.